Corbus Pharmaceuticals Holdings, Inc.

NASDAQ:CRBP

Biotechnology

Healthcare
$2.44 +1.73%

+$0.14 today

Market cap
$50.18M
Beta
2.59
P/E (TTM)
-1.3
EPS (TTM)
-$6.35
52W Low $6.72High $20.56

Volume 0.66M

Average 0.42M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$64.49M

FY 2025 · Annual

Investing Cash Flow

-$1.64M

FY 2025 · Annual

Financing Cash Flow

$77.43M

FY 2025 · Annual

-53.5% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(45.64M)(42.35M)(44.6M)(40.21M)(78.54M)
Depreciation & Amortization1.64M1.49M641K(2.74M)(1.13M)
Deferred Income Tax00000
Stock-Based Compensation9.48M5.72M3.47M6.15M6.29M
Change in Working Capital(15.7M)(4.02M)4.09M(5.58M)9.12M
Accounts Receivables1.62M0000
Inventory00000
Accounts Payables(5.96M)(256.84K)1.03M1.6M(2.35M)
Other Working Capital(11.36M)(3.77M)3.07M(7.18M)11.47M
Other Non-Cash Items2.03M1.62M3.77M585K(229K)
Operating Cash Flow(48.18M)(37.54M)(36.1M)(41.79M)(64.49M)
Capital Expenditures(54.17K)(13.45K)30(7K)
Acquisitions (Net)08.1K000
Purchases of Investments(87.27M)(86.34M)(33.88M)(180.8M)(163.09M)
Sales of Investments13.88M116.42M69.53M59.49M161.46M
Other Investing Activities23.9K0000
Investing Cash Flow(73.42M)30.07M35.64M(121.31M)(1.64M)
Debt Repayment57.78K(533.62K)(2.87M)(15.48M)0
Common Stock Issued62.59M053.4K182.06M77.43M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.82M)0000
Financing Cash Flow60.82M(533.62K)(2.82M)166.58M77.43M
Effect of Forex Changes00000
Net Change in Cash(60.78M)(8M)(3.28M)3.47M11.29M
Free Cash Flow(48.24M)(37.56M)(36.1M)(41.79M)(64.5M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$78.5M
+ D&A-$1.1M
+ Stock-Based Comp$6.3M
+ Deferred Tax$0
+ Working Capital$9.1M
- Other Non-Cash-$229.0K
= Operating Cash Flow-$64.5M
- Capex-$7.0K
= Free Cash Flow-$64.5M

Analysis

FY2025 free cash flow is -$64.5M. FCF conversion is 82.1% of net income. Operating cash flow was -$64.5M, with capex of -$7.0K. The largest bridge item is Working Capital at $9.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
SC 13G/ASC 13G/A filingNov 2, 2026

Does CRBP generate free cash flow?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) generated -$64.50M of free cash flow in fiscal 2025.

How much operating cash flow does CRBP produce?

Operating cash flow was -$64.49M, before capital expenditures of $7,000.00.